Ginlix AI
50% OFF

In-depth Analysis of Zhipu AI's R&D Investment and Profitability Prospects

#large_language_model #ai_industry #earnings_analysis #profitability #investment_analysis #chinese_tech #ipo
Neutral
A-Share
January 1, 2026

Unlock More Features

Login to access AI-powered analysis, deep research reports and more advanced features

In-depth Analysis of Zhipu AI's R&D Investment and Profitability Prospects

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.

In-depth Analysis of Zhipu AI’s R&D Investment and Profitability Prospects
I. Overview of Core Financial Data

Based on Zhipu AI’s HKEX prospectus and latest financial data, the company demonstrates typical characteristics of a large model startup:

high R&D investment, rapid revenue growth, continuous losses
[1][2][3].

R&D Investment Status:

  • 2022: 84.4 million yuan
  • 2023: 528.9 million yuan (527% year-on-year growth)
  • 2024: 2.1954 billion yuan (315% year-on-year growth)
  • First half of 2025: 1.5947 billion yuan
  • Cumulative R&D investment exceeds 4.4 billion yuan
    [3]

Revenue Growth Trend:

  • 2022: 57.4 million yuan
  • 2023: 124.5 million yuan (117% year-on-year growth)
  • 2024: 312.4 million yuan (151% year-on-year growth)
  • First half of 2025: 190 million yuan
  • Compound annual growth rate (CAGR) of up to 130%
    [2]

Analysis of R&D Expense to Revenue Ratio:

In the first half of 2025, Zhipu AI’s R&D expense to revenue ratio reached as high as
835.4%
, far exceeding the level of normal tech companies[1]. This means that for every 1 yuan of revenue generated, the company invests over 8 yuan in R&D. This ratio further increased from 702.8% in 2024, reflecting that Zhipu is still increasing technical investment to maintain competitiveness.


II. Loss Reasons and Financial Health Status

Current Status of Continuous Losses:

  • 2022: Loss of 144 million yuan
  • 2023: Loss of 788 million yuan
  • 2024: Loss of 2.958 billion yuan
  • First half of 2025: Loss of 2.358 billion yuan[3]

Main Reasons for Losses:

  1. High R&D Investment
    : R&D expense is the main operating expense item; in 2024, R&D expenditure was 7 times revenue
  2. Computing Power Infrastructure Construction
    : Large model training requires massive GPU computing power investment
  3. Talent Reserve Cost
    : The R&D team has 657 people, accounting for 74% of total employees, with substantial salary expenses
  4. Commercialization Still in Early Stage
    : Although revenue growth rate is fast, the absolute value is still small, making it difficult to cover high costs

Positive Factors:

  • Stable Gross Margin
    : Maintained in the range of 50%-65% over the past three years, 50% in the first half of 2025[2]
  • Sufficient Cash Reserves
    : As of the end of June 2025, cash and cash equivalents amounted to 2.52 billion yuan[1]
  • Cumulative Financing Exceeds 8.3 Billion Yuan
    : Shareholders include well-known institutions such as Meituan, Tencent, Xiaomi, etc.[3]

III. Technical Breakthroughs and Commercialization Progress

Core Technical Advantages:

  • GLM architecture achieved nationwide localization breakthrough, compatible with over 40 domestic chips
  • Multimodal models and agent models cover full scenarios such as language, code, vision, etc.
  • Core research team published 500 top high-impact papers, with cumulative citations exceeding 58,000 times
  • OpenAI listed Zhipu as a major global competitor in its industry analysis report in June 2025[3]

Commercialization Performance:

  • Enterprise customers: 12,000 (as of September 30, 2025)
  • Terminal devices: Over 80 million units
  • Developers: Over 45 million
  • Daily cloud token call volume: Over 4.2 trillion times (November 2025)
  • GLM Coding Plan overseas business: Revenue over 100 million yuan, paid developers over 150,000[1]

Market Position:

Based on 2024 revenue, Zhipu is China’s largest independent large model vendor, ranking second among all general-purpose large model developers with a market share of 6.6%[2].


IV. Profitability Timeline Forecast

Based on existing financial data and development trends, a scenario analysis of Zhipu AI’s profitability prospects is conducted:

Key Assumptions:

  • Revenue maintains current 130% CAGR (optimistic) or drops to 80% (neutral)
  • R&D investment growth rate gradually slows down
  • Scale effect gradually emerges, gross margin maintains around 50%
  • Cash reserves can support operations until the end of 2027

Scenario Forecast:

Scenario 2027 Revenue Scale R&D Expense Ratio Break-even Time
Optimistic 1.5-2.0 billion yuan 200%-300% Second half of 2027
Neutral 800 million-1.2 billion yuan 300%-400% 2028
Conservative 500 million-800 million yuan 400%-500% 2029 or later

Core Conclusions:

  1. Short-term (2025-2026)
    : Profitability is extremely unlikely. R&D investment will remain high; the company’s strategic priority is technical leadership rather than profit
  2. Mid-term (2027-2028)
    : Key turning point. If revenue can reach a scale of over 1 billion yuan, combined with slowing R&D investment growth, it is expected to approach break-even
  3. Long-term (after 2029)
    : With the expansion of commercialization scale and emergence of scale effects, profitability will gradually improve[3]

V. Investment Risks and Opportunities

Main Risks:

  • Technology Iteration Risk
    : AI technology changes rapidly; continuous large-scale investment may be needed to maintain competitiveness
  • Increased Competition
    : Fierce competition among domestic and foreign large model vendors; price wars may compress gross margins
  • Commercialization Below Expectations
    : Uncertainty exists in enterprise customers’ willingness and ability to pay
  • Valuation Pressure
    : As the “world’s first large model stock”, the market will scrutinize its commercialization capabilities with strict standards

Core Advantages:

  • First-mover Advantage: The earliest independent vendor to layout large models in China
  • Technical Barriers: 500 high-impact papers and localized architecture
  • Capital Reserves: 2.52 billion yuan in cash + 8.3 billion yuan in financing, sufficient to support R&D for many years
  • Shareholder Background: Supported by industrial capital such as Meituan, Tencent, Xiaomi, etc.

Conclusion

Zhipu AI’s current R&D expense ratio (over 800%) reflects the

typical characteristics of the early stage of the large model industry
: exchanging technical investment for long-term competitive advantages. The company is still far from profitability; it is expected to approach break-even in
2027-2028
, but the specific time depends on whether revenue growth rate can be maintained, whether R&D investment can be effectively controlled, and whether the commercialization process goes smoothly.

As the “world’s first large model stock”, Zhipu’s listing will fill the gap of lack of public market valuation references in the large model industry, and also means that its business model and profitability will undergo public scrutiny from the capital market. For investors, it is necessary to closely monitor its commercialization progress, technology iteration speed, and changes in the competitive landscape.


References

[1] QbitAI - Breaking Analysis of Zhipu AI’s Prospectus: Annual Revenue 300 Million Yuan, 130% Growth Rate, Leading the Sprint for the World’s First Large Model Stock (https://www.qbitai.com/2025/12/362256.html)

[2] Wall Street CN - Breaking Analysis of Zhipu AI’s Prospectus: Annual Revenue 300 Million Yuan, 130% Growth Rate (https://wallstreetcn.com/articles/3761776)

[3] CLS - Is the “World’s First Large Model Stock” Coming? Zhipu’s “Fundamentals” Exposed: Revenue 312 Million Yuan, Valuation 24.3 Billion Yuan (https://www.cls.cn/detail/2235451)

Ask based on this news for deep analysis...
Alpha Deep Research
Auto Accept Plan

Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.